Janus kinase (JAK) inhibitors are not associated with an increased risk for gastrointestinal perforation (GIP) among patients with rheumatoid arthritis (RA), according to study results published in ...

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

Intravenous ibuprofen appears safe and effective for older adults, reducing postoperative pain and opioid consumption.

Among older adults who sustained a hip fracture, a significant proportion demonstrated varying levels of resilience across different HRQOL domains.

The association of low-carbohydrate (LCD) and low-fat diets (LFD) with coronary heart disease (CHD) risk depends on the quality of macronutrients.

Women residing in US neighborhoods with high social vulnerability have a higher risk for earlier natural menopause.

For patients evaluated for acute coronary syndrome, replacing sedentary behavior with sleep, light-intensity physical activity, or moderate- to vigorous-intensity physical activity is associated with ...

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Between 1999 and 2019 in the US, deaths related to hypertrophic cardiomyopathy decreased, but then significantly increased during the COVID-19 pandemic.